Search research articles
Contact Us
Filters
Showing results (121-130 of 200) with videos related to
Page
of 20
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)
|
November 29, 2008
Can comprehensive stroke centers erase the 'weekend effect'?
Karen C Albright, Rema Raman, Karin Ernstrom, et al.
The New England Journal of Medicine
|
January 24, 2014
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease
Rachelle S Doody, Ronald G Thomas, Martin Farlow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 25, 2022
Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Miriam T Ashford, Rema Raman, Garrett Miller, et al.
Age and Ageing
|
January 22, 2026
Prevalence of frailty and its association with cognition in preclinical Alzheimer's disease: a cross-sectional analysis of baseline data from the A4 study
Andrew L H Huynh, Shunran Wang, Kathryn Lee, et al.
JAMA Neurology
|
June 23, 2020
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial
Suzanne Craft, Rema Raman, Tiffany W Chow, et al.
The New England Journal of Medicine
|
July 26, 2013
A phase 3 trial of semagacestat for treatment of Alzheimer's disease
Rachelle S Doody, Rema Raman, Martin Farlow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 14, 2022
Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under-represented populations
Monica Rivera Mindt, Ozioma Okonkwo, Michael W Weiner, et al.
Psychological Trauma : Theory, Research, Practice and Policy
|
June 21, 2016
Randomized controlled trial of acceptance and commitment therapy for distress and impairment in OEF/OIF/OND veterans
Ariel J Lang, Paula P Schnurr, Sonia Jain, et al.
JAMA
|
November 4, 2010
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial
Joseph F Quinn, Rema Raman, Ronald G Thomas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 25, 2014
Estimating long-term multivariate progression from short-term data
Michael C Donohue, Hélène Jacqmin-Gadda, Mélanie Le Goff, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 200) with videos related to
Sort By:
Page
of 20
Cerebrovascular Diseases (Basel, Switzerland)
|
November 29, 2008
Can comprehensive stroke centers erase the 'weekend effect'?
Karen C Albright, Rema Raman, Karin Ernstrom, et al.
The New England Journal of Medicine
|
January 24, 2014
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease
Rachelle S Doody, Ronald G Thomas, Martin Farlow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 25, 2022
Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Miriam T Ashford, Rema Raman, Garrett Miller, et al.
Age and Ageing
|
January 22, 2026
Prevalence of frailty and its association with cognition in preclinical Alzheimer's disease: a cross-sectional analysis of baseline data from the A4 study
Andrew L H Huynh, Shunran Wang, Kathryn Lee, et al.
JAMA Neurology
|
June 23, 2020
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial
Suzanne Craft, Rema Raman, Tiffany W Chow, et al.
The New England Journal of Medicine
|
July 26, 2013
A phase 3 trial of semagacestat for treatment of Alzheimer's disease
Rachelle S Doody, Rema Raman, Martin Farlow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 14, 2022
Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under-represented populations
Monica Rivera Mindt, Ozioma Okonkwo, Michael W Weiner, et al.
Psychological Trauma : Theory, Research, Practice and Policy
|
June 21, 2016
Randomized controlled trial of acceptance and commitment therapy for distress and impairment in OEF/OIF/OND veterans
Ariel J Lang, Paula P Schnurr, Sonia Jain, et al.
JAMA
|
November 4, 2010
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial
Joseph F Quinn, Rema Raman, Ronald G Thomas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 25, 2014
Estimating long-term multivariate progression from short-term data
Michael C Donohue, Hélène Jacqmin-Gadda, Mélanie Le Goff, et al.
Page
of 20